Lithuanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
coccidioidomycosis/karščiavimas
Nuoroda įrašoma į mainų sritį
Puslapis 1 nuo 29 rezultatus
Antiviral rift valley fever virus peptides and methods of use
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to novel, broad-spectrum, antiviral peptides, compositions containing one or more of these, and their use for the prophylactic treatment against and/or therapeutic treatment of infection by hemorrhagic fever viruses
Reverse genetic system for rift valley fever virus and uses thereof
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to the field of molecular biology, virology and immunology. More specifically, the present invention provides a reverse genetic system for Rift Valley fever virus (RVFV) and discloses its use in the
Vaccines against rift valley fever virus
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
TABLE OF CONTENTS
1. Field of the Invention
2. Background of the Invention
2.1. Recombinant DNA Technology and Gene Expression
2.2. Vaccines
2.3. Rift Valley Fever
2.4. Rift Valley Fever Virus
3. Summary of the Invention
4. Brief Description of the Figures
5. Detailed Description of the
Rift Valley Fever Virus glycoproteins, Gn and Gc, and their use
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates generally to immunoreagents, and more specifically to Rift Valley fever Virus (RVFV) glycoproteins and their use as vaccine components and as moieties for disease diagnosis and detection, including methods of using such
Rift valley fever virus replicon particles and use thereof
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD
This disclosure concerns Rift Valley Fever virus replicon particles (VRPs), methods of making VRPs and their use as vaccines against Rift Valley Fever virus infection.
BACKGROUND
Rift Valley fever virus (RVFV) causes sporadic but devastating outbreaks of severe human disease and widespread
Recombinant rift valley fever virus encoding a dominant-negative inhibitor of DSRNA-dependent protein kinase in the NSS region
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
REFERENCE TO SEQUENCE LISTING
A sequence listing required by 37 CFR 1.821-1.825 is being submitted electronically with this application. The sequence listing is incorporated herein by reference.
BACKGROUND
Rift Valley fever (RVF) is a mosquito-borne zoonotic disease in humans and ruminants that is
Recombinant rift valley fever (RVF) viruses and methods
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD
This disclosure concerns recombinant RVF viruses comprising deletions in viral virulence genes. These recombinant viruses can be used as vaccines to prevent RVF virus infection. This disclosure further relates to a reverse genetics system used to generate recombinant RVF
Recombinant rift valley fever (RVF) viruses and methods of use
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD
This disclosure concerns recombinant RVF viruses comprising deletions in viral virulence genes. These recombinant viruses can be used as vaccines to prevent RVF virus infection. This disclosure further relates to a reverse genetics system used to generate recombinant RVF
Recombinant Rift Valley fever (RVF) viruses and methods of use
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD
This disclosure concerns recombinant RVF viruses comprising deletions in viral virulence genes. These recombinant viruses can be used as vaccines to prevent RVF virus infection. This disclosure further relates to a reverse genetics system used to generate recombinant RVF
Peptide and DNA immunization against Coccidioides immitis infections
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to the fields of pathogenic fungi and immunology. More particularly, the invention provides compositions of peptides and genetic constructs expressing the peptides and methods of using such compositions in
Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with Arenaviruses
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION
The present invention relates to the use of sulfonyl semicarbazides, semicarbazides and ureas, as well as derivatives and analogs thereof, and pharmaceutical compositions containing the same, for the treatment or prophylaxis of viral infections and diseases associated
Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION
The present invention relates to the use of sulfonyl semicarbazides, semicarbazides and ureas, as well as derivatives and analogs thereof, and pharmaceutical compositions containing the same, for the treatment or prophylaxis of viral infections and diseases associated
Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
SEQUENCE LISTING
The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Jan. 21, 2011, is named 56441024.txt and is 9,154 bytes in size.
FIELD
The use of sulfonyl
Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
SEQUENCE LISTING
The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Feb. 9, 2011, is named 5644102.txt and is 9,265 bytes in size.
FIELD OF THE INVENTION
The
Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena viruses
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
SEQUENCE LISTING
The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Oct. 12, 2011, is named 56441026.txt and is 7,802 bytes in size.
FIELD
The use of sulfonyl
Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu
- Dirba 55 kalbomis
- Žolelių gydymas, paremtas mokslu
- Vaistažolių atpažinimas pagal vaizdą
- Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
- Skaitykite mokslines publikacijas, susijusias su jūsų paieška
- Ieškokite vaistinių žolelių pagal jų poveikį
- Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus
Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais
